Ladies, are you looking for an anabolic and muscle support aid that is formulated for you? Never settle for trying to dose prohormones designed for men again! Fematrope is a non-hormonal, all-natural anabolic formula that promotes gains in muscle mass, growth, and recovery, all in one supplement! Fematrope is the ultimate versatile anabolic support supplement, and can be easily stacked. And you won't have to worry about all of those potentially nasty side effects of other prohormones, as it is a non-hormonal formula!
Take 1 serving (1 capsule) twice daily with a meal. For best results, it is recommended to take one serving with your pre-training meal to optimize nutrient uptake and performance.
Serving Size: 1 Capsules
Servings per Container: 60
Amount per Serving % DV*
Lean Muscle Amplification Matrix 375mg
Eriobotrya japonica (Loquat) (25% Ursolic Acid) 250mg **
Apigenin 75mg **
AstraGin (Astragalus membranaceous and Panax notoginseng (root) Extract) 50mg **
*Daily Values Based on a 2,000 calorie diet.
**Daily Values not established.
Other ingredients: Modified cellulose gum, vegetable stearates, silicon dioxide.
Not for use by individuals under the age of 18 years. Do not use if pregnant or nursing. Keep out of reach of children. Do not consume this product if you have a medical condition and/or taking any prescription medication. Do not exceed recommended servings, and do not use this product if you are at risk or are being treated for high blood pressure, kidney, thyroid, psychiatric disease, anxiety, depression, seizure, enlarged prostate, or stroke. Before beginning any supplement or training program, always consult a physician first.
Shih CC, Lin CH, Wu JB. Eriobotrya japonica improves hyperlipidemia and reverses insulin resistance in high-fat-fed mice. Phytother Res. 2010;24(12):1769-1780. doi:10.1002/ptr.3143
Zwickey H, Brush J, Iacullo CM, et al. The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD25 expression in humans: a pilot study. Phytother Res. 2007;21(11):1109-1112. doi:10.1002/ptr.2207